Rchr
J-GLOBAL ID：201801014608188249   Update date: Jun. 09, 2023

Fujitaka Kazunori

フジタカ カズノリ | Fujitaka Kazunori
Affiliation and department：
Hiroshima University

About Hiroshima University


Research field  (1)： Respiratory medicine
Papers (69)：
  • Masuda, Takeshi, Fujitaka, Kazunori, Suzuki, Tomoko, Hamai, Kosuke, Matsumoto, Naoko, Matsumura, Mirai, Isoyama, Shoko, Ueno, Sayaka, Mito, Mineyo, Yamaguchi, Kakuhiro, et al. Phase 2 study of first-line pembrolizumab monotherapy in elderly patients with non-small-cell lung cancer expressing high PD-L1. THORACIC CANCER. 2022. 13. 11. 1611-1618
  • Harada, Hideyuki, Omori, Shota, Mori, Keita, Konno, Masahiro, Murakami, Haruyasu, Imagumbai, Toshiyuki, Fukuda, Haruyuki, Nakamatsu, Kiyoshi, Kimura, Tomoki, Tanabe, Hiroaki, et al. Multi-institutional feasibility study of intensity-modulated radiotherapy with chemotherapy for locally advanced non-small cell lung cancer. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY. 2022. 27. 6. 1025-1033
  • Miura, Shinichiro, Iwamoto, Hiroshi, Omori, Keitaro, Yamaguchi, Kakuhiro, Sakamoto, Shinjiro, Horimasu, Yasushi, Masuda, Takeshi, Miyamoto, Shintaro, Nakashima, Taku, Fujitaka, Kazunori, et al. Accelerated decline in lung function in adults with a history of remitted childhood asthma. EUROPEAN RESPIRATORY JOURNAL. 2022. 59. 1
  • Watari, Naokazu, Yamaguchi, Kakuhiro, Masuda, Takeshi, Ito, Noriaki, Sakamoto, Shinjiro, Horimasu, Yasushi, Miyamoto, Shintaro, Nakashima, Taku, Iwamoto, Hiroshi, Fujitaka, Kazunori, et al. Tolerability and efficacy of IMpower133 regimen modified for dialysis patients with extensive-stage small cell lung cancer: Two case reports. THORACIC CANCER. 2021. 12. 21. 2956-2960
  • Tsubata, Yukari, Masuda, Takeshi, Hamai, Kosuke, Taniwaki, Masaya, Tanino, Akari, Hotta, Takamasa, Hamaguchi, Megumi, Hamaguchi, Shunichi, Yamasaki, Masahiro, Ishikawa, Nobuhisa, et al. Efficacy of erlotinib and its effects on the quality of life of older patients with epidermal growth factor receptor-mutant non-small cell lung cancer: A prospective, multicenter, dose-modification study. GERIATRICS & GERONTOLOGY INTERNATIONAL. 2021. 21. 10. 881-886
ｍore...
Lectures and oral presentations  (131)：
  • A study of lung cancer cases participated in cancer genome medicine at our hospital
    (The 20th Annual Meeting of Japanese Society of Medical Oncology 2023)
  • The difference in predictive value for checkpoint inhibitor pneumonitis between serum and plasma levels of HMGB1
    (The 20th Annual Meeting of Japanese Society of Medical Oncology 2023)
  • 複合免疫療法による肺臓炎発症に対するリスク因子を検討する多施設共同後向き観察研究-ILAの関与の検討-
    (第63回日本肺癌学会学術集会 2022)
  • Interstitial lung abnormalitiesは非小細胞肺癌に対する化学放射線療法後デュルバルマブ投与中の肺臓炎に対するリスク因子である
    (第63回日本肺癌学会学術集会 2022)
  • HMGB1による抗PD-1/PD-L1抗体単剤療法の効果予測
    (第63回日本肺癌学会学術集会 2022)
ｍore...
Education (2)：
  • 1999 - 2002 Hiroshima University Graduate School, Division of Medical Sciences
  • 1987 - 1993 Hiroshima University Faculty of Medicine
Professional career (1)：
  • Doctor of Philosophy in Medical Science (Hiroshima University)
Work history (10)：
  • 2014/04/01 - 2019/03/31 Hiroshima University Institute of Biomedical & Health Sciences Lecturer
  • 2007/04/01 - 2014/03/31 Hiroshima University Hospital Assistant Professor
  • 2005/10/01 - 2007/03/31 Hiroshima University Hospital Research Associate
  • 2005/04/01 - 2005/09/30 Hiroshima University Hospital Clinical Fellow
  • 2004/05/01 - 2005/03/18 The University of Texas postdoctoral fellow
Show all
Association Membership(s) (2)：
Japanese Society of Medical Oncology ,  Japanese Cancer Association
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM